Elucidating the mechanisms of colistin resistance and the efficacy of combination therapy in MDR/XDR/PDR Acinetobacter baumannii

Elucidating the mechanisms of colistin resistance and the efficacy of combination therapy in MDR/XDR/PDR Acinetobacter baumannii

Bibliographic Details
Main Authors:	A. Abou Fayad, D. Abdul Ghani, W. Bazzi, G. Araj, G. Matar
Format:	Article
Language:	English
Published:	Elsevier 2020-12-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971220310377

Similar Items

Elucidating the efficacy of combination therapy and colistin resistance mechanisms in MDR/XDR Gram-negative Bacilli
by: Diana Abdulghani, et al.
Published: (2020-12-01)

Identification of Acinetobacter baumannii and Determination of MDR and XDR Strains
by: Noor Hussein Ahmad, et al.
Published: (2020-07-01)

Exploring Synergistic Combinations in Extended and Pan-Drug Resistant (XDR and PDR) Whole Genome Sequenced <i>Acinetobacter baumannii</i>
by: Munawr AL Quraini, et al.
Published: (2023-05-01)

Frequency of MDR and XDR Strains and Antibiotic Resistance Pattern of Acinetobacter baumannii Clinical Isolates in Sari Hospitals, Iran
by: Maryam Asadi Jouybari, et al.
Published: (2020-09-01)

Molecular Characteristics of Colistin Resistance in <i>Acinetobacter baumannii</i> and the Activity of Antimicrobial Combination Therapy in a Tertiary Care Medical Center in Lebanon
by: Antoine Abou Fayad, et al.
Published: (2024-02-01)

Pharmacodynamics of colistin against Acinetobacter baumannii
by: Mohd Rasidin, Rashizal Sazli
Published: (2017)

In vitro synergism of combinations of colistin with selected antibiotics against colistin-resistant Acinetobacter baumannii
by: Percin, Duygu, et al.
Published: (2014-08-01)

Comparison of the efficacy of colistin monotherapy and colistin combination therapies in the treatment of nosocomial pneumonia and ventilatorassociated pneumonia caused by Acinetobacter baumannii
by: Ä°skender Kara, et al.
Published: (2015-11-01)

Colistin Dependency among Colistin-Heteroresistant <i>Acinetobacter baumannii</i> Isolates
by: Hadas Kon, et al.
Published: (2021-12-01)

Two types of colistin heteroresistance in Acinetobacter baumannii isolates
by: Yoon-Kyoung Hong, et al.
Published: (2020-01-01)

Clinical and laboratory-induced colistin-resistance mechanisms in Acinetobacter baumannii.
by: Boinett, C, et al.
Published: (2019)

Synergistic Activity of Capsaicin and Colistin Against Colistin-Resistant Acinetobacter baumannii: In Vitro/Vivo Efficacy and Mode of Action
by: Tingting Guo, et al.
Published: (2021-09-01)

In vitro and in vivo synergistic effect of chrysin in combination with colistin against Acinetobacter baumannii
by: Yining Zhao, et al.
Published: (2022-10-01)

Prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) phenotypes of Pseudomonas aeruginosa and Acinetobacter baumannii isolated in clinical samples from Northeast of Iran
by: Bahman Mirzaei, et al.
Published: (2020-08-01)

Synergistic activities of colistin combined with other antimicrobial agents against colistin-resistant Acinetobacter baumannii clinical isolates.
by: Mashal M Almutairi
Published: (2022-01-01)

Synergistic activities of colistin combined with other antimicrobial agents against colistin-resistant Acinetobacter baumannii clinical isolates
by: Mashal M. Almutairi
Published: (2022-01-01)

Colistin for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex
by: Jun-Yuan Zheng, et al.
Published: (2020-12-01)

Production and Extraction of Siderophores-Catecholate- from -MDR-Acinetobacter baumannii
by: Baghdad Science Journal
Published: (2017-06-01)

Comparative genomics and molecular epidemiology of colistin-resistant Acinetobacter baumannii
by: Jovana Kabic, et al.
Published: (2023-01-01)

Risk Factors Associated With Colistin-Resistant Acinetobacter baumannii Infection
by: Hae-Sun Chung, et al.
Published: (2023-06-01)

The role of pmrCAB genes in colistin-resistant Acinetobacter baumannii
by: Shaimaa Mohamed Seleim, et al.
Published: (2022-12-01)

The effect of colistin resistance-associated mutations on the fitness of Acinetobacter baumannii
by: Xinli Mu, et al.
Published: (2016-11-01)

Colistin-Resistant Acinetobacter baumannii as a cause of Neonatal Ventriculitis
by: Prasha Mahabeer, et al.
Published: (2018-09-01)

Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii
by: Gabriela Jorge Da Silva, et al.
Published: (2017-11-01)

Transmission of MDR and XDR tuberculosis in Shanghai, China.
by: Ming Zhao, et al.
Published: (2009-01-01)

The induction and identification of novel Colistin resistance mutations in Acinetobacter baumannii and their implications
by: Thi Khanh Nhu, N, et al.
Published: (2016)

Emergence and Persistence of High-Risk Clones Among MDR and XDR A. baumannii at a Brazilian Teaching Hospital
by: Laís Calissi Brisolla Tavares, et al.
Published: (2019-01-01)

Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin–sulbactam combination therapy
by: Sukrit Srisakul, et al.
Published: (2022-07-01)

Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones.
by: Mostafa A Mohammed, et al.
Published: (2020-01-01)

Molecular characterization and clonal dynamics of nosocomial blaOXA-23 producing XDR Acinetobacter baumannii.
by: Sabrina Royer, et al.
Published: (2018-01-01)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
by: Shi H, et al.
Published: (2019-12-01)

Analysis of colistin resistance in carbapenem-resistant and XDR
by: Raunak Bir, et al.
Published: (2022-02-01)

Efficacy of Lysophosphatidylcholine as Direct Treatment in Combination with Colistin against <i>Acinetobacter baumannii</i> in Murine Severe Infections Models
by: Andrea Miró-Canturri, et al.
Published: (2021-02-01)

Efficacy of colistin and rifampin combination for treatment of ventilator associated pneumonia caused by carbapenem resistant Acinetobacter baumannii: brief report
by: Masoomeh Sofian, et al.
Published: (2020-02-01)

Economic impact of an outbreak of MDR Acinetobacter baumannii in a second level hospital
by: E. Becerra, et al.
Published: (2020-12-01)

War, antimicrobial resistance, and Acinetobacter baumannii (WAMRA)
by: A. Abou Fayad, et al.
Published: (2020-12-01)

Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatment
by: Jeongwoo Jo, et al.
Published: (2023-06-01)

In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant Acinetobacter Baumannii
by: Alessandra Oliva, et al.
Published: (2019-03-01)

PYED-1 Overcomes Colistin Resistance in <i>Acinetobacter baumannii</i>
by: Maria Stabile, et al.
Published: (2023-11-01)

Colistin Treatment Affects Lipid Composition of <em>Acinetobacter baumannii</em>
by: Ye Tao, et al.
Published: (2021-05-01)